Malaria

The device is targeted at severely ill malaria patients who have been hospitalised and prescribed IV drug treatment. These are the most vulnerable patients, including children, pregnant women and immune deficient patients, and can have mortality rates up to 20%.

Latest News

Position closed: Biochemistry Laboratory Associate 

Position closed: Biochemistry Laboratory Associate 
Created on 7/10/2018 5:01:26 PM

You may have seen that last month, MediSieve was recruiting for a Biochemistry Laboratory Associ...
The best medical technology innovations at TLA’s HealthTech Innovator conference

The best medical technology innovations at TLA’s HealthTech Innovator conference
Created on 7/6/2018 9:12:39 AM

Tech London Advocates’ (TLA) HealthTech Working Group and the Health Foundry organised the HealthT...